Nature Communications,
Journal Year:
2019,
Volume and Issue:
10(1)
Published: May 1, 2019
Abstract
Small
intestinal
bacterial
overgrowth
(SIBO)
has
been
implicated
in
symptoms
associated
with
functional
gastrointestinal
disorders
(FGIDs),
though
mechanisms
remain
poorly
defined
and
treatment
involves
non-specific
antibiotics.
Here
we
show
that
SIBO
based
on
duodenal
aspirate
culture
reflects
an
of
anaerobes,
does
not
correspond
patient
symptoms,
may
be
a
result
dietary
preferences.
microbial
composition,
the
other
hand,
is
significantly
altered
symptomatic
patients
results.
In
pilot
interventional
study
found
switching
from
high
fiber
diet
to
low
fiber,
simple
sugar
triggered
FGID-related
decreased
small
diversity
while
increasing
permeability.
Our
findings
demonstrate
characterizing
microbiomes
allow
more
targeted
antibacterial
or
diet-based
approach
treatment.
Nutrients,
Journal Year:
2020,
Volume and Issue:
12(5), P. 1474 - 1474
Published: May 19, 2020
The
gut
microbiota
is
emerging
as
a
promising
target
for
the
management
or
prevention
of
inflammatory
and
metabolic
disorders
in
humans.
Many
current
research
efforts
are
focused
on
identification
specific
microbial
signatures,
more
particularly
those
associated
with
obesity,
type
2
diabetes,
cardiovascular
diseases.
Some
studies
have
described
that
obese
animals
humans
exhibits
higher
Firmicutes/Bacteroidetes
ratio
compared
normal-weight
individuals,
proposing
this
an
eventual
biomarker.
Accordingly,
frequently
cited
scientific
literature
hallmark
obesity.
aim
present
review
was
to
discuss
validity
potential
marker,
based
great
amount
contradictory
results
reported
literature.
Such
discrepancies
might
be
explained
by
existence
interpretative
bias
generated
methodological
differences
sample
processing
DNA
sequence
analysis,
generally
poor
characterization
recruited
subjects
and,
particularly,
lack
consideration
lifestyle-associated
factors
known
affect
composition
and/or
diversity.
For
these
reasons,
it
currently
difficult
associate
determined
health
status
specifically
consider
Frontiers in Microbiology,
Journal Year:
2021,
Volume and Issue:
12
Published: June 23, 2021
The
novel
virus
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
caused
a
pandemic
of
disease
2019
(COVID-19).
Across
the
globe,
subset
patients
who
sustain
an
SARS-CoV-2
infection
are
developing
wide
range
persistent
symptoms
that
do
not
resolve
over
course
many
months.
These
being
given
diagnosis
Long
COVID
or
Post-acute
sequelae
COVID-19
(PASC).
It
is
likely
individual
with
PASC
have
different
underlying
biological
factors
driving
their
symptoms,
none
which
mutually
exclusive.
This
paper
details
mechanisms
by
RNA
viruses
beyond
just
be
connected
to
long-term
health
consequences.
also
reviews
literature
on
and
other
virus-initiated
chronic
syndromes
such
as
post-Ebola
myalgic
encephalomyelitis/chronic
fatigue
(ME/CFS)
discuss
scenarios
for
symptom
development.
Potential
contributors
include
consequences
from
injury
one
multiple
organs,
reservoirs
in
certain
tissues,
re-activation
neurotrophic
pathogens
herpesviruses
under
conditions
immune
dysregulation,
interactions
host
microbiome/virome
communities,
clotting/coagulation
issues,
dysfunctional
brainstem/vagus
nerve
signaling,
ongoing
activity
primed
cells,
autoimmunity
due
molecular
mimicry
between
pathogen
proteins.
individualized
nature
suggests
therapeutic
approaches
may
required
best
manage
care
specific
diagnosis.
Gut,
Journal Year:
2017,
Volume and Issue:
67(6), P. 1024 - 1032
Published: Aug. 1, 2017
Objectives
We
aimed
to
characterise
the
microbial
changes
associated
with
histological
stages
of
gastric
tumourigenesis.
Design
performed
16S
rRNA
gene
analysis
mucosal
samples
from
81
cases
including
superficial
gastritis
(SG),
atrophic
(AG),
intestinal
metaplasia
(IM)
and
cancer
(GC)
Xi’an,
China,
determine
microbiome
dysbiosis
across
GC.
validated
results
in
126
Inner
Mongolia,
China.
Results
observed
significant
mucosa
IM
GC
subjects,
enrichment
21
depletion
10
bacterial
taxa
compared
SG
(q<0.05).
Microbial
network
showed
increasing
correlation
strengths
among
them
disease
progression
(p<0.001).
Five
GC-enriched
whose
species
identifications
correspond
Peptostreptococcus
stomatis
,
Streptococcus
anginosus
Parvimonas
micra
Slackia
exigua
Dialister
pneumosintes
had
centralities
ecological
(p<0.05)
classified
an
area
under
receiver-operating
curve
(AUC)
0.82.
Moreover,
stronger
interactions
microbes
were
Helicobacter
pylori
-negative
H.
-positive
IM.
The
fold
selected
bacteria,
their
successfully
Mongolian
cohort,
which
five
markers
distinguished
AUC
0.81.
Conclusions
In
addition
compositional
changes,
we
identified
differences
carcinogenesis.
enrichments
suggest
potentially
important
roles
P.
D.
S.
progression.
Cancers,
Journal Year:
2019,
Volume and Issue:
11(1), P. 38 - 38
Published: Jan. 3, 2019
Cancer
is
a
multifactorial
pathology
and
it
represents
the
second
leading
cause
of
death
worldwide.
In
recent
years,
numerous
studies
highlighted
dual
role
gut
microbiota
in
preserving
host’s
health.
Gut
resident
bacteria
are
able
to
produce
number
metabolites
bioproducts
necessary
protect
gut’s
homeostasis.
Conversely,
several
subpopulations
may
expand
during
pathological
dysbiosis
therefore
high
levels
toxins
capable,
turn,
trigger
both
inflammation
tumorigenesis.
Importantly,
can
interact
with
host
either
modulating
directly
epithelium
or
immune
system.
Numerous
populating
bacteria,
called
probiotics,
have
been
identified
as
protective
against
genesis
tumors.
Given
their
capability
homeostasis,
probiotics
currently
tested
help
fight
cancer
patients
subjected
chemotherapy
radiotherapy.
Most
recently,
three
independent
show
that
specific
species
potentiate
positive
outcome
anti-cancer
immunotherapy.
The
highly
significant
studies,
uncovering
tight
association
between
tumorigenesis,
well
therapy,
here
described.
Lactobacillus
rhamnosus
GG
(LGG),
most
studied
probiotic
model
cancer,
also
reported.
Overall,
according
findings
summarized,
novel
strategies
integrating
such
LGG,
conventional
therapies
strongly
encouraged.
npj Parkinson s Disease,
Journal Year:
2021,
Volume and Issue:
7(1)
Published: March 10, 2021
The
gut
microbiota
is
emerging
as
an
important
modulator
of
neurodegenerative
diseases,
and
accumulating
evidence
has
linked
microbes
to
Parkinson's
disease
(PD)
symptomatology
pathophysiology.
PD
often
preceded
by
gastrointestinal
symptoms
alterations
the
enteric
nervous
system
accompany
disease.
Several
studies
have
analyzed
microbiome
in
PD,
but
a
consensus
on
features
PD-specific
missing.
Here,
we
conduct
meta-analysis
re-analyzing
ten
currently
available
16S
datasets
investigate
whether
common
patients
exist
across
cohorts.
We
found
significant
PD-associated
microbiome,
which
are
robust
study-specific
technical
heterogeneities,
although
differences
structure
between
controls
small.
Enrichment
genera
Lactobacillus,
Akkermansia,
Bifidobacterium
depletion
bacteria
belonging
Lachnospiraceae
family
Faecalibacterium
genus,
both
short-chain
fatty
acids
producers,
emerged
most
consistent
alterations.
This
dysbiosis
might
result
pro-inflammatory
status
could
be
recurrent
affecting
patients.
Clinical & Experimental Immunology,
Journal Year:
2018,
Volume and Issue:
195(1), P. 74 - 85
Published: June 19, 2018
The
microbiome
is
represented
by
microorganisms
which
live
in
a
symbiotic
way
with
the
mammalian.
Microorganisms
have
ability
to
influence
different
physiological
aspects
such
as
immune
system,
metabolism
and
behaviour.
In
recent
years,
several
studies
highlighted
role
of
pathogenesis
autoimmune
diseases.
Notably,
systemic
lupus
erythematosus
an
alteration
intestinal
flora
(lower
Firmicutes/Bacteroidetes
ratio)
has
been
described.
Conversely,
changes
gut
commensal
periodontal
disease
proposed
important
factors
rheumatoid
arthritis.
At
same
time,
other
diseases
(i.e.
sclerosis,
Sjögren's
syndrome
anti-phospholipid
syndrome)
also
share
modifications
tract
oral
flora.
Herein,
we
describe
maintenance
homeostasis
system
then
alterations
that
occur
Finally,
will
consider
use
probiotics
faecal
transplantation
novel
therapeutic
targets.
Cell Reports,
Journal Year:
2015,
Volume and Issue:
12(10), P. 1656 - 1667
Published: Aug. 29, 2015
Alterations
in
the
composition
of
intestinal
microbiota
have
been
correlated
with
aging
and
measures
frailty
elderly.
However,
relationships
between
microbial
dynamics,
age-related
changes
physiology,
organismal
health
remain
poorly
understood.
Here,
we
show
that
dysbiosis
microbiota,
characterized
by
an
expansion
Gammaproteobacteria,
is
tightly
linked
to
age-onset
barrier
dysfunction
Drosophila.
Indeed,
alterations
precede
predict
onset
aged
flies.
Changes
occurring
prior
contribute
excretory
function
immune
gene
activation
intestine.
In
addition,
a
distinct
shift
follows
dysfunction,
leading
systemic
death.
Our
results
indicate
dynamics
could
also
varying
rates
decline
during
mammals.